Cincinnati Eye Institute - Blue Ash

Cincinnati, Ohio 45242-5664

0 studies enrolling now · 2 studies all time

What they study most

Choroideremia, Glaucoma, Ocular Hypertension, X-Linked Retinitis Pigmentosa

Studies at this site

• Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa — Completed
• Efficacy and Safety Assessment of T4032 (Unpreserved Bimatoprost 0.01%) Versus Lumigan® 0.01% in Ocular Hypertensive or Glaucomatous Patients — Completed